"Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Descriptor ID |
D009369
|
| MeSH Number(s) |
C04
|
| Concept/Terms |
Neoplasms- Neoplasms
- Neoplasia
- Neoplasias
- Neoplasm
- Tumors
- Tumor
Cancer- Cancer
- Cancers
- Malignant Neoplasms
- Malignant Neoplasm
- Neoplasm, Malignant
- Neoplasms, Malignant
- Malignancy
- Malignancies
Benign Neoplasms- Benign Neoplasms
- Neoplasms, Benign
- Benign Neoplasm
- Neoplasm, Benign
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms".
This graph shows the total number of publications written about "Neoplasms" by people in this website by year, and whether "Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 43 | 16 | 59 |
| 1995 | 51 | 13 | 64 |
| 1996 | 57 | 13 | 70 |
| 1997 | 55 | 15 | 70 |
| 1998 | 76 | 13 | 89 |
| 1999 | 61 | 25 | 86 |
| 2000 | 91 | 11 | 102 |
| 2001 | 96 | 24 | 120 |
| 2002 | 124 | 34 | 158 |
| 2003 | 151 | 29 | 180 |
| 2004 | 166 | 39 | 205 |
| 2005 | 186 | 36 | 222 |
| 2006 | 163 | 35 | 198 |
| 2007 | 204 | 39 | 243 |
| 2008 | 205 | 48 | 253 |
| 2009 | 230 | 34 | 264 |
| 2010 | 272 | 50 | 322 |
| 2011 | 277 | 46 | 323 |
| 2012 | 278 | 26 | 304 |
| 2013 | 321 | 43 | 364 |
| 2014 | 355 | 42 | 397 |
| 2015 | 337 | 38 | 375 |
| 2016 | 333 | 46 | 379 |
| 2017 | 379 | 56 | 435 |
| 2018 | 388 | 56 | 444 |
| 2019 | 397 | 29 | 426 |
| 2020 | 468 | 38 | 506 |
| 2021 | 450 | 29 | 479 |
| 2022 | 430 | 6 | 436 |
| 2023 | 416 | 10 | 426 |
| 2024 | 241 | 82 | 323 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms" by people in Profiles.
-
Perioperative Implications of Biologics and Immunotherapy. Adv Anesth. 2024 Dec; 42(1):97-113.
-
Update on Recommendations for Cancer Screening and Surveillance in Children with Genomic Instability Disorders. Clin Cancer Res. 2024 Nov 15; 30(22):5009-5020.
-
Exploring paraptosis as a therapeutic approach in cancer treatment. J Biomed Sci. 2024 Nov 04; 31(1):101.
-
Update on Pediatric Cancer Surveillance Recommendations for Patients with Neurofibromatosis Type 1, Noonan Syndrome, CBL Syndrome, Costello Syndrome, and Related RASopathies. Clin Cancer Res. 2024 Nov 01; 30(21):4834-4843.
-
A Phase 1 Study of ABI-009 (Nab-sirolimus) in Combination With Temozolomide and Irinotecan in Pediatric Patients With Recurrent or Refractory Solid Tumors, Including CNS Tumors-A Children's Oncology Group Pediatric Early Phase Clinical Trial Network Study ADVL1514. Cancer Med. 2024 Nov; 13(21):e70376.
-
Adavosertib in Combination with Olaparib in Patients with Refractory Solid Tumors: An Open-Label, Dose-Finding, and Dose-Expansion Phase Ib Trial. Target Oncol. 2024 Nov; 19(6):879-892.
-
Tumour-intrinsic PDL1 signals regulate the Chk2 DNA damage response in cancer cells and mediate resistance to Chk1 inhibitors. Mol Cancer. 2024 Oct 30; 23(1):242.
-
Developmental-status-aware transcriptional decomposition establishes a cell state panorama of human cancers. Genome Med. 2024 Oct 28; 16(1):124.
-
TGF-? trap of AdAPT-001 turns up the heat on tumors and turns down checkpoint blocker resistance. J Immunother Cancer. 2024 Oct 26; 12(10).
-
Development of an Educational Website for Patients With Cancer and Preexisting Autoimmune Diseases Considering Immune Checkpoint Blockers: Usability and Acceptability Study. JMIR Cancer. 2024 10 25; 10:e53443.